IMMUNOLOGICAL EFFECTS OF ALTERNATIVE WEEKLY INTERFERON-ALPHA-2B AND LOW-DOSE INTERLEUKIN-2 IN PATIENTS WITH CANCER

被引：8
|
作者：
FIORENTINO, B
DISTEFANO, P
GIULIANI, C
AMATETTI, C
TINARI, N
NATOLI, C
GARUFI, C
IACOBELLI, S
机构：
[1] UNIV G DANNUNZIO, CATTEDRA ONCOL MED, VIA DEI VESTINI 66, I-66100 CHIETI, ITALY
[2] UNIV G DANNUNZIO, CATTEDRA ENDOCRINOL, I-66100 CHIETI, ITALY
来源：
BRITISH JOURNAL OF CANCER | 1992年 / 66卷 / 05期
关键词：
D O I：
10.1038/bjc.1992.396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：981 / 983
页数：3
相关论文
共 50 条
  • [1] IMMUNOLOGICAL MONITORING OF PATIENTS WITH ADVANCED KIDNEY CANCER TREATED WITH LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND INTERLEUKIN-2
    MASUCCI, G
    WERSALL, P
    MELLSTEDT, H
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 406 - 406
  • [2] TREATMENT OF CHRONIC HEPATITIS-B WITH INTERFERON-ALPHA-2B AND INTERLEUKIN-2
    BRUCH, HR
    KORN, A
    KLEIN, H
    MARKUS, R
    MALMUS, K
    BAUMGARTEN, R
    MULLER, R
    JOURNAL OF HEPATOLOGY, 1993, 17 : S52 - S55
  • [3] A PHASE-I STUDY OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA-2B
    SZNOL, M
    MIER, JW
    SPARANO, J
    GAYNOR, ER
    WEISS, GR
    MARGOLIN, KA
    BAR, MH
    HAWKINS, MJ
    ATKINS, MB
    DUTCHER, JP
    FISHER, RI
    BOLDT, DH
    DOROSHOW, JH
    LOUIE, A
    ARONSON, FR
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (06): : 529 - 537
  • [4] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
  • [5] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon - Reply
    McDermott, DF
    Regan, MM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6268 - 6269
  • [6] HOME THERAPY WITH RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED HUMAN MALIGNANCIES
    ATZPODIEN, J
    KORFER, A
    FRANKS, CR
    POLIWODA, H
    KIRCHNER, H
    LANCET, 1990, 335 (8704): : 1509 - 1512
  • [7] Response rates of patients with metastatic melanoma to high-dose intravenous interleukin-2 after prior exposure to alpha-interferon or low-dose interleukin-2
    Weinreich, DM
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (02): : 185 - 187
  • [8] HEMATOLOGIC EFFECTS OF LOW-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH CONCOMITANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC SOLID MALIGNANCIES
    DAVE, HPG
    WHITE, C
    SCHULOF, R
    AVIS, FP
    CLINICAL RESEARCH, 1991, 39 (02): : A430 - A430
  • [9] Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
    Giovannelli, Ilaria
    Bayatti, Nadhim
    Brown, Abigail
    Wang, Dennis
    Mickunas, Marius
    Camu, William
    Veyrune, Jean-Luc
    Payan, Christine
    Garlanda, Cecilia
    Locati, Massimo
    Juntas-Morales, Raul
    Pageot, Nicolas
    Malaspina, Andrea
    Andreasson, Ulf
    Suehs, Carey
    Saker, Safa
    Masseguin, Christophe
    de Vos, John
    Zetterberg, Henrik
    Al-Chalabi, Ammar
    Leigh, P. Nigel
    Tree, Timothy
    Bensimon, Gilbert
    Heath, Paul R.
    Shaw, Pamela J.
    Kirby, Janine
    BRAIN COMMUNICATIONS, 2021, 3 (03)
  • [10] IMMUNOLOGICAL EFFECTS OF THERAPY WITH LOW-DOSE CYCLOPHOSPHAMIDE (CY) AND RECOMBINANT INTERLEUKIN-2 (IL2)
    HAREL, W
    SHAU, H
    HADLEY, C
    STAHLBERG, J
    REISFELD, R
    CHERESH, D
    MITCHELL, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 401 - 401
12345